Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion description "[As circulating chromogranin-A (CgA) levels are found to correlate with tumor progression and the status of hormone refractoriness, our current study attempted to assess whether CgA-positive cells would be preferentially distributed in epithelial structures with FBCLD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion evidence source_evidence_literature NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion SIO_000772 21980038 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion wasDerivedFrom befree-20150227 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion wasGeneratedBy ECO_0000203 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.